TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits.
Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.
Development of phenotype algorithms using electronic medical records and incorporating natural language processing.
Toward high-throughput phenotyping: unbiased automated feature extraction and selection from knowledge sources.
